Fundraising FoxBroadview Ventures — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Aeromics is a clinical-stage pharmaceutical company developing AER-271, an intravenous aquaporin-4 (AQP4) inhibitor designed to prevent cerebral edema (brain swelling) following severe, acute ischemic stroke.
BiotechHealthtechNew Haven, US
Dr. Pelletier(Co-founder)Dr. Boron(Founder)Marc Pelletier(Manager, Chief Executive Officer)William Boron(Co-founder)Paul McGuirk(Executive Officer)George Farr(Executive Officer)
Co-investorsConnecticut Innovations
FineHeart develops the FlowMaker®, a wirelessly powered, fully implantable mechanical circulatory support device designed to optimize cardiac output for patients with severe heart failure.
AI & Machine LearningDeep TechHealthtechMedical DevicesBordeaux, FR
Arnaud Mascarell(CEO)inDr. Stephane Garrigue(Founder, Inventor)Dr. Philippe Ritter(Co-founder)
Co-investorsAQUITI GestionM Capital Partners
Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY dissolving on the tongue to activate brain regions regulating food intake and metabolism.
BiotechDigital HealthHealthtechLongevityMinneapolis, US
Jon Freeman(Executive Officer)Donald R. Johns(Chief Medical Officer)Thomas J. Vasicek(Executive Officer, Director, Promoter)
BoardChristopher de Souza(Director)inRichard Horan(Director)
Co-investorsArgonautic VenturesHarvard Business Angels of ChicagoiSelect FundElephant Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.